NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054106

Registered date:12/04/2024

Retrospective observational study of patients with atopic dermatitis in remission with Upadacitinib.

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedAtopic Dermatitis
Date of first enrollment2024/04/20
Target sample size300
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRemission maintenance rate at 1 year after achieving remission with Upadacitinib
Secondary OutcomeUpadacitinib for atopic dermatitis: the actual treatment of atopic dermatitis.

Key inclusion & exclusion criteria

Age minimum12years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Cases of use clearly off-label for Upadacitinib 2) Patients who have requested to refuse to participate in the study

Related Information

Contact

public contact
Name RYOICHI TAGUCHI
Address Shibamatsuobiru 4F, 2-9-1 Shibakoen, Minato-ku, Tokyo-to Japan 1050011
Telephone 0364353833
E-mail ryoichi_taguchi@ebc-m.com
Affiliation EBC&M LLC Clinical Division
scientific contact
Name YUICHIRO TSUNEMI
Address 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama Japan
Telephone 049-276-1111
E-mail cr-info@ebc-m.com
Affiliation Saitama Medical University Hospital Department of Dermatology